Insights
Expert analysis across healthcare, life science, pharma, veterinary, social care and digital.
-
Capabilities
-
Capabilities
-
Healthcare Services Overview
-
Behavioural and Mental HealthThe most outsourced of all clinical specialties
-
Children's Services and EducationOperators of special educational needs schools, alternative provision, and education services for children requiring additional support
-
Care Homes
-
Clinical HomecareSpecialist providers administering high-acuity treatments such as infusions, biologics and oncology therapies in the home setting
-
Clinical LaboratoriesLaboratory networks and pathology operators delivering diagnostic testing to hospitals, clinics, and consumers
-
General HospitalsClear strategy on portfolios, pathways and payors
-
Specialist Hospitals & ClinicsOperators of acute hospitals, day-surgery and outpatient facilities including opthalmic, imaging centres, cancer and radiotherapy clinics, and ambulance services
-
Workforce & Support ServicesStaffing agencies, locum platforms and other service providers supplying clinicians and other essential support functions
-
-
Capabilities
-
Health Systems & Payors Overview
-
NHSPublic health systems including NHS Trusts, Integrated Care Boards and Local Authorities
-
Commissioning & System DesignAuthorities and commissioning bodies shaping financial models and system architecture, including NICE and national commissioners here in the UK
-
Private Health InsurersManaged care organisations, health insurers and payors financing and reimbursing healthcare
-
-
Capabilities
-
Pharma Overview
-
Consumer HealthProviders of dentistry, optical, audiology, fertility, pharmacy, and wellness services, including fast-growing retail and patient-pay segments
-
Innovative PharmaThe large originator companies that invest heavily in R&D and drive global therapeutic innovation
-
BiotechEmerging and mid-cap biopharma firms, often venture-backed and focused on advancing new platforms and modalities
-
Generic PharmaGenerics, biosimilars and specialty pharma companies focus on cost-competitive supply or niche formulation and complex / hospital-only medicines.
-
Radiopharma
-
Speciality Pharma
-
Pharma Services (SMOs/CROs)Contract research organisations and site management organisations deliver outsourced trial execution and patient recruitment.
-
Pharma Manufacturing Services (CDMOs)CDMOs support pharma & biotech with process development, scale-up and contract manufacturing.
-
-
Capabilities
-
Life Sciences Overview
-
Advanced Modalities & TherapiesDevelopers of next-generation approaches such as cell and gene therapies, oligonucleotide and RNA technologies, genomics & proteomics
-
Lab Equipment & ConsumablesCompanies supplying laboratory instruments, benchtop equipment, single-use technologies and consumables
-
Research Tools & TechnologiesProviders of reagents, assays, bioinformatics platforms, and discovery systems
-
-
Capabilities
-
Med Tech Overview
-
Devices & ImplantsManufacturers of high-tech medical devices such as cardiac implants, orthopaedics, neuromodulation systems, stents and wound-care products
-
Diagnostics & MonitoringFirms in imaging, in-vitro diagnostics, digital monitoring and point-of-care testing
-
Equipment & ConsumablesSuppliers of surgical tools, hospital equipment and single-use products
-
-
Capabilities
-
Capabilities
-
Market Mapping and SizingShows where opportunities exist and their scale, through structured market analysis.
-
Country EntryGuides entry into new geographies, supported by risk–benefit assessment and route-to-market planning.
-
Strategic MarketingStrengthens how you reach and engage customers, drawing on segmentation and positioning tools.
-
Competitive PositioningClarifies how to stand out and defend share, using competitor benchmarking and strategy frameworks.
-
-
Capabilities
-
Revenue Quality AssessmentExamines the durability of income, using customer, contract, and market analysis.
-
Revenue at RiskExamines the durability of income, using customer, contract, and market analysis.
-
Market Opportunity AssessmentIdentifies and quantifies growth potential, supported by market sizing and forecast models.
-
Pricing ValidationTests how sustainable current prices are, informed by customer feedback and market evidence.
-
Health Technology AssessmentEvaluates adoption potential and reimbursement prospects through structured evidence review.
-
-
Capabilities
-
Competitive AnalysisCompares strengths and weaknesses against peers, using structured benchmarking.
-
Value Creation AdvisoryPinpoints the actions that drive growth and efficiency, aligned to investor and board priorities.
-
Underperformance DiagnosticsIdentifies the real causes of missed targets, using root-cause and capability analysis.
-
Multi-Business Portfolio ReviewTests whether the portfolio is strategically coherent, supported by capital allocation and fit analysis.
-
Local Market BenchmarkingMeasures how performance compares locally, using peer benchmarks and market data.
-
Market-Model Fit AssessmentExamines how well the business model matches market dynamics, using practical fit-for-purpose tests.
-
Board-Level Performance NarrativesDevelops clear, evidence-based stories for governance and stakeholder communication.
-
Repositioning RecommendationsDefines how to reset direction, based on market trends and competitive realities.
-
-
Capabilities
-
Go-To-MarketLays out the path to customers, informed by adoption patterns and channel economics.
-
Pricing and ReimbursementBuilds approaches that balance payer, provider, and patient value, grounded in reimbursement rules.
-
Public-Private PartnershipsShapes collaborations that expand access, supported by practical partnership structures.
-
Organisation DesignAligns teams and structures with strategy, using operating-model and governance design.
-
-
Capabilities
-
Digital Maturity AssessmentGauges readiness for change, using staged capability assessments.
-
Value-Based Care Digital EnablementBuilds digital enablers for outcomes-based health, guided by value-based care frameworks.
-
Health Strategy and Systems DesignDesigns digitally enabled health systems, informed by system-level commissioning models.
-
Digital IntegrationConnects platforms and data, supported by interoperability and system architecture.
-
Digital Investment Strategy and PrioritisationDirects capital to the initiatives with the greatest impact, using portfolio prioritisation tools.
-
-
About Us
About Us
-
Our People
Our People
